Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Subscribe To Our Newsletter & Stay Updated
